Published in Gene Therapy Weekly, October 18th, 1999
Dr. Victor Dzau, Brigham and Women's Hospital and Harvard University in Boston, Massachusetts, said the method could mean bypasses will last longer for many people who get them - good news because many bypasses clog up after a few years.
"It is absolutely safe," Dzau told a seminar for science reporters sponsored by Harvard.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.